Search

everythinglearnresearchcommunity

for

Search:↓

A 50-year-old woman with breast cancer developed an autoimmune skin disorder, highlighting the need for thorough checks and team-based treatment.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

A woman regrew her hair after receiving injections of special cell-derived vesicles.

A woman with breast cancer developed a rare condition causing excessive fine hair growth on her face and body.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Oral minoxidil can potentially increase hair growth in people suffering from Central Centrifugal Cicatricial Alopecia.

CK 5/6 expression in breast cancer is linked to negative hormone receptor status and higher tumor grade.

Extramammary Paget disease can spread deeply into tissues, reaching up to 3.6 mm.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

Some chemotherapy can cause permanent hair loss.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Breast cancer skin metastases are rare, look different, and can be confused with other skin issues, so a biopsy is needed for accurate diagnosis.

Most cutaneous adnexal tumors examined were benign and resembled common skin tumors.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

Chemotherapy significantly lowers Inhibin A levels in breast cancer patients.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Wearing a wig caused a woman's skin condition to worsen due to pressure from the wig's fasteners.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

New markers and pathways have been found in skin tumors, helping better understand and diagnose them.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Human skin produces sex hormones like estrogen and testosterone, influenced by ARO and StAR, which may affect skin elasticity and hair growth.

Chemotherapy can cause hair changes similar to alopecia areata, which might lead to misdiagnosis.

Cellular senescence has both cancer-blocking and cancer-promoting effects, and targeting senescent cells may improve health and lifespan.